Remove 2027 Remove Insurance Remove Packaging
article thumbnail

STAT+: Key House panel proposes lowering out-of-pocket drug costs in Medicare

STAT

The House Ways & Means Committee package includes a new provision that would ensure that patients in the Medicare program pay for medicines they pick up at the pharmacy counter based on the discounted price that insurers negotiate with drugmakers, instead of higher sticker prices, starting in 2027.

article thumbnail

STAT+: Pharmalittle: Biogen to slash 1,000 more jobs; key House panel proposes lowering Medicare out-of-pocket drug costs

STAT

The House Ways & Means Committee proposed a package that includes a new provision to ensure Medicare patients pay for medicines they pick up at pharmacies based on discounted prices insurers negotiate with drugmakers, instead of higher list prices, starting in 2027 , STAT reports.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How much is Nexplanon without insurance?

The Checkup by Singlecare

Is Nexplanon covered by insurance? | How much does Nexplanon cost without insurance? | How to get Nexplanon without insurance Nexplanon is a brand-name prescription birth control implant that does not contain estrogen. in 2027 and other countries in 2025, when a generic version may be approved.

article thumbnail

Vor Bio back from brink with autoimmune drug deal rising to $4bn

Pharmaceutical Technology

The study, which is expected to produce initial results in the first half of 2027, will support potential approval in the US and Europe. By GlobalData Learn more about Strategic Intelligence RemeGen is conducting a global Phase III clinical trial with telitacicept for the treatment of generalised myasthenia gravis.

article thumbnail

BioOrbit eyes 2026 for pre-clinical trials of space manufactured protein crystals

Pharmaceutical Technology

Then, we will need to run pre-clinical trials of these crystals, which will be in 2026 or 2027. Then the next step is to produce meaningful quantities of these crystals, which will be next year.” After that, it will be about compliance and regulation, as we must ensure that all our processes adhere to pharma regulations.

article thumbnail

EHDS regulation will depend on strong patient confidence

Pharmaceutical Technology

The European Commission (EC) faces a March 2027 deadline to adopt several key implementing acts, which will lay out detailed rules for putting the regulation into practice. The regulation came into force in March 2025; however, it has not yet come into application, with this set to happen in March 2029.

article thumbnail

Merck concludes SpringWorks acquisition for $3.4bn

Pharmaceutical Technology

The merger, announced in April 2025 , will positively impact Merck’s financial position by contributing to revenues immediately, and is anticipated to be accretive to its earnings per share by 2027. How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.